3 recruiting, 3 unknown, 2 completed. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Recruiting 3, Unknown 3, Completed 2 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow gimeracil: new trials by email Literature Review of gimeracil trials Research Report on gimeracil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or Without Ipilimumab N01 in Resectable Gastric/Gastroesophageal Junction Adenocarcinoma tegafur, Gimeracil and Oteracil Potassium Capsules, Sintilimab Placebo, Sintilimab - Resectable Gastric/Gastroesophageal Junction Adenocarcinoma | Phase 2 / Phase 3 | Recruiting | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 720 | 2026-07-31 | 2026-08-14 |
| Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer GFH375, Chemotherapy - Metastatic Pancreatic Cancer | Phase 3 | Recruiting | Genfleet Therapeutics (Shanghai) Inc. | 320 | 2025-12-04 | 2026-08-14 |
| S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） S-1 for 9 months, S-1 for 1 year - Gastric Cancer | Phase 3 | Recruiting | Fudan University | 1006 | 2019-01-01 | 2019-05-31 |
| A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites Oxaliplatin, Paclitaxel, S-1 (Tegafur, Gimeracil and Oteracil Porassium Capsules) - Gastric Cancer, Stomach Neoplasms | Phase 3 | Unknown | Fudan University | 215 | 2018-03-16 | 2018-03-23 |
| Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer Oxaliplatin, Gimeracil and Oteracil Potassium Capsule, Endostar injection - Gastric Cancer | Phase 3 | Unknown | Tang Xushan | 120 | 2013-08-01 | 2013-12-11 |
| Perioperative Chemotherapy for Potentially Resectable Gastric Cancer Tegafur, Gimeracil and Oteracil Potassium Capsules；Oxaliplatin, Oxaliplatin; Capecitabine - Gastric Cancer | Phase 2 / Phase 3 | Completed | Hebei Medical University | 749 | 2012-02-01 | 2020-02-13 |
| Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer Docetaxel (XRP6976), Oxaliplatin (SR96669), S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil) - Gastric Cancer | Phase 3 | Completed | Sanofi | 530 | 2011-12-30 | 2023-12-13 |
| Trial of S-1 Plus Cisplatin in Gastric Cancer s-1 plus cisplatin, 5-Fu plus cisplatin - Gastric Cancer | Phase 3 | Unknown | Sun Yat-sen University | 270 | 2008-09-01 | 2011-07-25 |
Stomach Neoplasms (6) · Pancreatic Neoplasms (1)
Fudan University (2) · Genfleet Therapeutics (Shanghai) Inc. (1) · Hebei Medical University (1) · Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. (1) · Sanofi (1) · Sun Yat-sen University (1) · Tang Xushan (1)
China (7) · South Korea (1)
Dazhi Xu, PHD, MD (1) · Qun Zhao, Doctor (1) · Tang Yong, Professor (1)
PMID 26439700, PMID 32583567, PMID 34133211, PMID 37501640, PMID 38996201